Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Greenwich LifeSciences, Inc. (GLSI)
|
|
| Cash Flow Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Net income | -1.6 | -2.8 | -2.3 | -0.7 | -2.0 | -2.4 | -0.9 | -0.7 |
| Depreciation and amortization [+] | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Amortization of intangible assets | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Stock-based compensation | | 0.6 | 0.8 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Change in working capital [+] | | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.2 | 0.0 |
| Accounts payable | | | | | | -0.1 | -0.3 | |
| Other | | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.1 | 0.0 |
| Cash from operations | -1.6 | -2.2 | -1.5 | -0.5 | -1.9 | -2.3 | -0.9 | -0.6 |
| |
| Capital expenditures | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash from investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| |
| Issuance of common stock, net | | | | 5.5 | -5.5 | 0.6 | | |
| Other cash from financing | | | | -7.5 | | | | |
| Cash from financing | 0.0 | 0.0 | 0.0 | -2.0 | -5.5 | 0.6 | 0.0 | 0.0 |
| |
| Free cash flow | -1.6 | -2.2 | -1.5 | -0.5 | -1.9 | -2.3 | -0.9 | -0.6 |
| Per share (diluted) | ($0.13) | ($0.17) | ($0.12) | ($0.04) | ($0.15) | ($0.17) | ($0.07) | ($0.05) |
|